Abstract:BACKGROUND: The presence of tumor deposits (TDs) is only considered in the absence of lymph node metastases (LNMs) in the current TNM staging system. However, the prognostic value of TDs when concomitant with LNM for rectal cancer after neoadjuvant chemoradiotherapy (NCRT) remains unclear. This study aimed to evaluate the prognostic value of TDs and when concomitant with LNMs in rectal cancer after NCRT.METHODS: Patients with rectal cancer who had received NCRT between 2010 and 2016 were obtained from the Surveillance, Epidemiology and End Results (SEER) 18 (year range, 1975-2016) database. Data were extracted on the following: age, sex, race, TNM stage, total LNs harvested, positive LNs, histologic type, perineural invasion, grade, carcinoma embryonic antigen status, TD number, and cancer-specific survival (CSS) rates. The primary objective was to determine the prognostic impact of TDs on CSS. The effect of the addition of TD to the LNM count for a novel N stage was also evaluated. Univariate and multivariate analyses were performed using the Kaplan-Meier method and Cox models.RESULTS: Of 9,620 patients, 865 (9.0%) had TDs. TD-positive patients showed a worse prognosis than TD-negative patients (HR =2.39, 95% CI: 2.04-2.80, P<0.001), and multivariate analysis showed that the presence of TDs was an independent poor prognostic factor (HR =1.41, 95% CI: 1.19-1.67, P<0.001). Regarding the LN status, TDs were associated with a higher risk of cancer-specific death in the LNM- group (HR =2.43, 95% CI: 1.86-3.18, P<0.001), M1 group (HR =1.51, 95% CI: 1.08-2.10, P<0.001), and ypN1 group (HR =2.08, 95% CI: 1.61-2.70, P<0.001), but not in the ypN2 group (HR =0.97, 95% CI: 0.69-1.36, P=0.84). Patients with concomitant TDs and LNM showed significantly worse survival than those with TDs or LNM alone (5-year CSS: 48.2%, 72.2%, and 67.8%, respectively). The 5-year CSS rates were 86.2%, 77.4%, 65.1%, 53.8%, and 46.5% for the novel N0, N1a, N1b, N2a, and N2b groups, respectively (P<0.05 across all groups). Time dependent receiver operating characteristic curve analysis and decision curve analysis showed that the novel N stage was superior to the current ypN stage.CONCLUSIONS: The presence of TDs is an independent poor prognostic factor for LARC patients after NCRT. The concomitant presence of TDs and LNM indicates a significantly worse survival, and the addition of TD to LNM may help to better prompt appropriate risk stratification.

Value of Transrectal Ultrasonography for Tumor Node Metastasis Restaging in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy.

Evaluation of the T-restaging and Effect after Neoadjuvant Chemotherapy in Advanced Gastric Carcinoma Using Double Contrast-Enhanced Ultrasonography

The Optimal Application of Transrectal Ultrasound in Staging of Rectal Cancer Following Neoadjuvant Therapy: A Pragmatic Study for Accuracy Investigation

Endosonography Elastography and Magnetic Resonance Imaging in the Restaging and Response Assessment of Rectal Cancer After Neoadjuvant Therapy

Magnetic Resonance Imaging in Restaging Rectal Cancer after Neoadjuvant Chemoradiotherapy.

Preoperative T and N Restaging of Rectal Cancer After Neoadjuvant Chemoradiotherapy: An Accuracy Comparison Between MSCT and MRI

The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy

Evaluation of current imaging in restaging rectal cancer after neoadjuvant therapy

Application of Transrectal Elastography and Contrast-Enhanced Ultrasound in Evaluation of the Efficacy of Neoadjuvant Therapy for Rectal Cancer

Contrast-enhanced MRI for T Restaging of Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy and Radiation Therapy

The Value of Restaging with Chest and Abdominal CT/MRI Scan after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.

Pathological Assessment of the Ajcc Tumor Regression Grading System after Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer

Application value of different sequences magnetic resonance imaging in rectal cancer re-staging after neoadjuvant chemoradiation therapy

Value of endorectalultrasonography in preoperative assessment of rectal cancer post neoadjuvantchemoradiation therapy

Application of endorectal elastography to evaluate local advanced rectal cancer after neoadjuvant radiochemotherapy:compared with pathology

A New Magnetic Resonance Imaging Tumour Response Grading Scheme for Locally Advanced Rectal Cancer

Prognostic Significance of Clinical and Pathological Stages on Locally Advanced Rectal Carcinoma after Neoadjuvant Chemoradiotherapy

Preoperative staging of rectal tumors: comparison of endorectal ultrasound, hydro-CT, and high-resolution endorectal MRI

Prognostic and staging value of tumor deposits in patients with rectal cancer after neoadjuvant chemoradiotherapy

Prognostic Effects of Clinical and Pathologic Tnm Stages in Patients with Locally Advanced Rectum Carcinoma after Neoadjuvant Chemoradiotherapy

Application and Influencing Factors of Endorectal Ultrasound in T-stage Restaging of Rectal Cancer Following Neoadjuvant Therapy